Nufarm Limited (ASX: NUF) is building momentum after delivering a 25% increase in underlying earnings, positive free cash flow and a stronger balance sheet in FY26. With its Seed Technologies division expanding rapidly and restructuring benefits beginning to emerge, the agricultural chemicals group is showing encouraging signs of a sustained financial recovery.
The key question now is whether Nufarm can build on this progress and translate improving operational performance into stronger profitability and shareholder value.
Key Numbers: Nufarm's FY26 Financial Recovery
- $378.3 million underlying EBITDA, up 25% for the year ended 30 September 2026.
- $19.9 million underlying net profit after tax, reversing a $22.9 million loss in FY25.
- $28 million positive free cash flow, representing a $158 million year-on-year improvement.
- $749 million net debt, down 9%, with leverage improving from 2.7 times to 2.0 times.
- $448.8 million Seed Technologies revenue, up 34%, with divisional EBITDA reaching $86.4 million.
Stronger Earnings Signal a More Efficient Business
Nufarm's FY26 results highlight the benefits of its ongoing operational transformation.
Despite group revenue declining approximately 7% to $3.21 billion, underlying EBITDA increased to $378.3 million, reflecting improved margins, disciplined cost management and a greater focus on higher-value products.
Underlying EBIT more than doubled to $165.2 million, while return on funds employed improved from 2.8% to 5.9%.
These improvements suggest Nufarm is becoming more efficient at converting revenue into operating earnings.
Although the company recorded a statutory net loss of $79.5 million, including $99.4 million in after-tax material items, much of the adjustment related to restructuring activities.
We see the improvement in underlying profitability as an encouraging indication that management's efforts to simplify the business are gaining traction.
Seed Technologies Emerges as a Powerful Growth Driver
One of the standout developments was the performance of Nufarm's Seed Technologies division.
Divisional EBITDA increased by $72.5 million to $86.4 million, supported by strong canola seed demand and improving Renewable Oils contributions.
The Seeds business generated $292.8 million in revenue, increasing 16%, while EBITDA climbed 22% to $81.8 million.
Growth across Australian and South American canola markets demonstrates the commercial strength of Nufarm's seed portfolio.
Renewable Oils also returned to positive EBITDA of $4.6 million, supported by improved Omega-3 pricing conditions.
Meanwhile, Crop Protection delivered $364.6 million in EBITDA despite challenging market conditions, with margins improving by 1.3 percentage points.
Importantly, net working capital declined 12% to $777.8 million, helping improve cash conversion and reduce financial pressure.
We think these developments demonstrate that Nufarm's growth opportunities are becoming better supported by operational and financial discipline.
What Nufarm Is Doing Now
Nufarm continues to reshape its operations around profitability, efficiency and higher-return opportunities.
The company has removed approximately 280 products and pack sizes from its North American portfolio, reducing complexity and strengthening its product mix.
It is also progressing manufacturing facility closures at Kwinana in Western Australia and Alsip in the United States.
Its restructuring programme targets $50 million in annualised cost savings by the end of FY27, providing a potential foundation for further margin improvements.
Within Renewable Oils, Nufarm has extended its carinata offtake agreement with bp until 2050, supporting long-term commercial opportunities in sustainable biofuel feedstocks.
These initiatives position the company to pursue growth while maintaining greater control over operating expenditure and capital requirements.
Insight: Is Nufarm Building a More Profitable Future?
We think Nufarm's FY26 performance marks an encouraging step towards a stronger and more sustainable business. The combination of expanding seed earnings, improving cash generation and declining leverage supports growing confidence in its operational recovery. Its Seed Technologies portfolio offers attractive growth potential, while restructuring savings could strengthen margins further. Although financing costs, remaining debt and modest returns on capital require continued attention, the direction of financial performance is positive. We believe sustained free cash flow generation and disciplined capital allocation will be the clearest indicators of whether this recovery can create lasting shareholder value.
What Happens Next?
Nufarm expects further underlying EBITDA growth in FY27, including mid-teens growth in Seed Technologies and mid-single-digit growth in Crop Protection, subject to seasonal and currency conditions.
Management also anticipates capital expenditure below $200 million, improving free cash flow and further reductions in net debt.
The company's leverage target of 1.5 to 2.0 times provides another measurable indicator of financial progress.
The next important milestone will be delivering restructuring savings while maintaining momentum across its core operations.
With stronger earnings, an expanding seed business and improving financial flexibility, Nufarm enters FY27 with a more encouraging outlook and an opportunity to demonstrate that its turnaround can deliver sustainable profitability.